Identification of altered microRNAs in serum of a mouse model of Parkinson’s disease
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 687, 1-9
Abstract
No abstract availableKeywords
Funding Information
- Oak Ridge Institute for Science and Education
- U.S. Department of Energy
- U.S. Food and Drug Administration
This publication has 41 references indexed in Scilit:
- RETRACTED: Elevated microRNA-125b promotes inflammation in rheumatoid arthritis by activation of NF-κB pathwayBiomedicine & Pharmacotherapy, 2017
- Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s diseaseJournal of Neural Transmission, 2017
- MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesiclesNeuroscience Letters, 2017
- Plasma levels of miR-137 and miR-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depressionNeurological Sciences, 2017
- MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System AtrophyMolecular Neurobiology, 2016
- Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatmentBehavioural Brain Research, 2015
- Biomarkers of Parkinson’s disease: Present and futureMetabolism, 2015
- Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's diseaseJournal of Neuroscience Research, 2014
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Deletion of theparkinandPACRGgene promoter in early-onset parkinsonismHuman Mutation, 2006